{"title":"循环肿瘤DNA分析:从发现到临床应用","authors":"Rui Zhang","doi":"10.3760/CMA.J.ISSN.1009-9158.2020.02.001","DOIUrl":null,"url":null,"abstract":"Circulating tumor DNA analysis is the focused issue in clinical research. A few of biomarkers have been used in clinical practice, while some are in the discovery phase. The key challenges for clinical laboratories on the way from discovery to clinical practice of the circulating tumor DNA analysis, including choosing the intended use based on evidence for clinical validity and utility, quality assurance for the testing process, reporting and interpretation for the results will be discussed. \n \n \nKey words: \nCirculating tumor DNA; Clinical laboratory techniques; Biomarkers","PeriodicalId":10096,"journal":{"name":"中华检验医学杂志","volume":"35 1","pages":"101-104"},"PeriodicalIF":0.0000,"publicationDate":"2020-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Circulating tumor DNA analysis:from discovery to clinical practice\",\"authors\":\"Rui Zhang\",\"doi\":\"10.3760/CMA.J.ISSN.1009-9158.2020.02.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Circulating tumor DNA analysis is the focused issue in clinical research. A few of biomarkers have been used in clinical practice, while some are in the discovery phase. The key challenges for clinical laboratories on the way from discovery to clinical practice of the circulating tumor DNA analysis, including choosing the intended use based on evidence for clinical validity and utility, quality assurance for the testing process, reporting and interpretation for the results will be discussed. \\n \\n \\nKey words: \\nCirculating tumor DNA; Clinical laboratory techniques; Biomarkers\",\"PeriodicalId\":10096,\"journal\":{\"name\":\"中华检验医学杂志\",\"volume\":\"35 1\",\"pages\":\"101-104\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-02-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中华检验医学杂志\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3760/CMA.J.ISSN.1009-9158.2020.02.001\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Health Professions\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华检验医学杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1009-9158.2020.02.001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Health Professions","Score":null,"Total":0}
Circulating tumor DNA analysis:from discovery to clinical practice
Circulating tumor DNA analysis is the focused issue in clinical research. A few of biomarkers have been used in clinical practice, while some are in the discovery phase. The key challenges for clinical laboratories on the way from discovery to clinical practice of the circulating tumor DNA analysis, including choosing the intended use based on evidence for clinical validity and utility, quality assurance for the testing process, reporting and interpretation for the results will be discussed.
Key words:
Circulating tumor DNA; Clinical laboratory techniques; Biomarkers